參考文獻(xiàn)/References:
[1] Güell E, Martín-Fernandez M, De la Torre M C, et al.Impact of lymphocyte and neutrophil counts on mortality risk in severe community-acquired pneumonia with or without septic shock[J].J Clin Med, 2019,8(5):754.
[2] Jouan Y, Si-Tahar M, Paget C.Severe pneumonia and acute respiratory distress syndrome:implication of unconventional T cells[J].Rev Mal Respir,2019,36(4):451-454.
[3] Kim J S, Lee J Y, Yang J W,et al.Immunopathogenesis and treatment of cytokine storm in COVID-19[J].2021,11(1):316-329.
[4] 楊桂華,袁瑋,梁亞慧,等.個(gè)案管理模式的應(yīng)用現(xiàn)狀與啟示[J].中華護(hù)理教育,2021,18(1): 92-96.
[5] 瞿介明,曹彬.中國(guó)成人社區(qū)獲得性肺炎診斷和治療指南(2016年版)[J].中華結(jié)核和呼吸雜志,2016,39(4):253-279.
[6] 尤黎明,吳瑛.內(nèi)科護(hù)理學(xué)[M].7版.北京:人民衛(wèi)生出版社,2022:137-140.
[7] Liu K, Chen Y, Lin R,et al.Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients[J].J Infect, 2020, 80(6):14-18.
[8] De Pascale G, Bello G, Tumbarello M, et al.Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature[J].Curr Opin Pulm Med,2012,18(3):213-221.
[9] 錢麗香,高麗娟,謝櫻.專科護(hù)士為主導(dǎo)的個(gè)案管理模式在新生兒重癥肺炎護(hù)理中的應(yīng)用[J].齊魯護(hù)理雜志,2023,29(1):124-126.
[10] Vanoni N M, Carugati M, Borsa N, et al.Management of acute respiratory failure due to community-acquired pneumonia: a systematic review[J].Med Sci(Basel), 2019, 7(1):10.
[11] 張雪,張思敏.循證護(hù)理在老年重癥肺炎合并心力衰竭護(hù)理中的應(yīng)用效果探討[J].心血管病防治知識(shí),2021,11(8):56-58.